| Ayodele O Olowookere, MD | |
|
400 Rosalind Redfern Grover Pkwy, Ste 281, Craddick Medical Office Building, Midland, TX 79701-5904 | |
| (432) 688-8888 | |
| (432) 686-8348 |
| Full Name | Ayodele O Olowookere |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 14 Years |
| Location | 400 Rosalind Redfern Grover Pkwy, Ste 281, Midland, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124350442 | NPI | - | NPPES |
| 214656501 | Medicaid | TX | |
| 8CG382 | Other | TX | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | N4638 (Texas) | Primary |
| Entity Name | Premier Family Care I, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275522864 PECOS PAC ID: 2567351372 Enrollment ID: O20040311000343 |
News Archive
The ELA association and Zinedine Zidane, its emblematic ambassador, are proud to announce a world premiere: the results regaring the gene therapy in adrenoleukodystrophy conducted in France have just been published in the prestigious journal Science. Two children have been treated and their diseases have been halted. The children are doing well, which is unexpected for a disease destroying the brain in a few months. This discovery opens up treatment perspectives for numerous widespread diseases.
Sixty percent of British people currently suffer from or have suffered from a skin disease at some point during their lifetime according to a new survey revealed at the British Skin Foundation's Skin Deep – 20 Years of Research conference on 13th October in London.
Adding another inhibitor to therapies that cut off a tumor's access to blood vessels could be the key to helping those therapies overcome resistance in glioblastoma, a deadly form of brain cancer.
One area, discussed in a recent paper by Northwestern University researchers and published on the preprint server medRxiv* in August 2020, is the viral exposure suffered by healthcare workers during bronchoalveolar lavage (BAL).
Against the background of the COVID-19 pandemic, the impact of SARS-CoV-2 infection in pregnancy has been a subject of much controversy. In order to help answer the question as to whether this infection causes significant harm in pregnancy, a new study, released as a medRxiv* preprint, reports on the disease outcomes of this infection in pregnant women.
› Verified 8 days ago
| Entity Name | Obhg Texas Holdings Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083917769 PECOS PAC ID: 3577713072 Enrollment ID: O20121018000279 |
News Archive
The ELA association and Zinedine Zidane, its emblematic ambassador, are proud to announce a world premiere: the results regaring the gene therapy in adrenoleukodystrophy conducted in France have just been published in the prestigious journal Science. Two children have been treated and their diseases have been halted. The children are doing well, which is unexpected for a disease destroying the brain in a few months. This discovery opens up treatment perspectives for numerous widespread diseases.
Sixty percent of British people currently suffer from or have suffered from a skin disease at some point during their lifetime according to a new survey revealed at the British Skin Foundation's Skin Deep – 20 Years of Research conference on 13th October in London.
Adding another inhibitor to therapies that cut off a tumor's access to blood vessels could be the key to helping those therapies overcome resistance in glioblastoma, a deadly form of brain cancer.
One area, discussed in a recent paper by Northwestern University researchers and published on the preprint server medRxiv* in August 2020, is the viral exposure suffered by healthcare workers during bronchoalveolar lavage (BAL).
Against the background of the COVID-19 pandemic, the impact of SARS-CoV-2 infection in pregnancy has been a subject of much controversy. In order to help answer the question as to whether this infection causes significant harm in pregnancy, a new study, released as a medRxiv* preprint, reports on the disease outcomes of this infection in pregnant women.
› Verified 8 days ago
| Entity Name | Ayodele O Olowookere, M.d., P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386061620 PECOS PAC ID: 4385869130 Enrollment ID: O20140710001553 |
News Archive
The ELA association and Zinedine Zidane, its emblematic ambassador, are proud to announce a world premiere: the results regaring the gene therapy in adrenoleukodystrophy conducted in France have just been published in the prestigious journal Science. Two children have been treated and their diseases have been halted. The children are doing well, which is unexpected for a disease destroying the brain in a few months. This discovery opens up treatment perspectives for numerous widespread diseases.
Sixty percent of British people currently suffer from or have suffered from a skin disease at some point during their lifetime according to a new survey revealed at the British Skin Foundation's Skin Deep – 20 Years of Research conference on 13th October in London.
Adding another inhibitor to therapies that cut off a tumor's access to blood vessels could be the key to helping those therapies overcome resistance in glioblastoma, a deadly form of brain cancer.
One area, discussed in a recent paper by Northwestern University researchers and published on the preprint server medRxiv* in August 2020, is the viral exposure suffered by healthcare workers during bronchoalveolar lavage (BAL).
Against the background of the COVID-19 pandemic, the impact of SARS-CoV-2 infection in pregnancy has been a subject of much controversy. In order to help answer the question as to whether this infection causes significant harm in pregnancy, a new study, released as a medRxiv* preprint, reports on the disease outcomes of this infection in pregnant women.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ayodele O Olowookere, MD Po Box 5426, Belfast, ME 04915-5400 Ph: (432) 686-6600 | Ayodele O Olowookere, MD 400 Rosalind Redfern Grover Pkwy, Ste 281, Craddick Medical Office Building, Midland, TX 79701-5904 Ph: (432) 688-8888 |
News Archive
The ELA association and Zinedine Zidane, its emblematic ambassador, are proud to announce a world premiere: the results regaring the gene therapy in adrenoleukodystrophy conducted in France have just been published in the prestigious journal Science. Two children have been treated and their diseases have been halted. The children are doing well, which is unexpected for a disease destroying the brain in a few months. This discovery opens up treatment perspectives for numerous widespread diseases.
Sixty percent of British people currently suffer from or have suffered from a skin disease at some point during their lifetime according to a new survey revealed at the British Skin Foundation's Skin Deep – 20 Years of Research conference on 13th October in London.
Adding another inhibitor to therapies that cut off a tumor's access to blood vessels could be the key to helping those therapies overcome resistance in glioblastoma, a deadly form of brain cancer.
One area, discussed in a recent paper by Northwestern University researchers and published on the preprint server medRxiv* in August 2020, is the viral exposure suffered by healthcare workers during bronchoalveolar lavage (BAL).
Against the background of the COVID-19 pandemic, the impact of SARS-CoV-2 infection in pregnancy has been a subject of much controversy. In order to help answer the question as to whether this infection causes significant harm in pregnancy, a new study, released as a medRxiv* preprint, reports on the disease outcomes of this infection in pregnant women.
› Verified 8 days ago
Reagan D'lynn Viney, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2500 W Illinois Ave, Suite 100, Midland, TX 79701 Phone: 432-699-2370 Fax: 432-697-3524 | |
Dr. Ronica Meera Mcbrayer, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2500 W Illinois Ave, Suite 100, Midland, TX 79701 Phone: 432-699-2370 Fax: 432-697-3524 | |
Dr. Ben W Doke, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2500 West Illinos, Suite 100, Midland, TX 79701 Phone: 432-699-2370 Fax: 432-697-3524 | |
Dr. Ernesto P Rhodes, M.D. PLLC Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2300 W Michigan Ave, Midland, TX 79701 Phone: 432-620-9001 Fax: 432-620-9003 | |
Leela Sharath Pillarisetty, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 400 Rosalind Redfern Grover Pkwy, Midland, TX 79701 Phone: 432-681-3100 | |
Dr. Gary D Madden, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2500 W Illinois Ave, Suite 100, Midland, TX 79701 Phone: 432-699-2370 Fax: 432-697-3524 |